1. Clinical Overview
Xylometazoline is a potent, direct-acting sympathomimetic amine used as a topical nasal decongestant. It is a selective alpha-2 adrenergic receptor agonist, causing vasoconstriction of the dilated arterioles in the nasal mucosa, leading to reduced blood flow, decreased edema, and relief of nasal congestion. The 1% w/v concentration is a standard strength for intranasal use in adults and children over 12 years.
| Onset | Duration | Bioavailability |
|---|---|---|
| 5-10 minutes | 8-12 hours (long-acting) | Negligible systemic absorption when used intranasally at recommended doses. |
2. Mechanism of Action
Xylometazoline acts as a direct agonist on postsynaptic alpha-2 adrenergic receptors located on vascular smooth muscle within the nasal mucosa. This stimulation activates the G-protein coupled receptor, leading to increased intracellular calcium levels, resulting in smooth muscle contraction (vasoconstriction). This constricts the dilated arterioles and venous sinusoids, reducing blood flow, capillary engorgement, and tissue edema, thereby shrinking the nasal turbinates and opening the nasal airway.
3. Indications & Uses
- Symptomatic relief of nasal congestion associated with allergic rhinitis (seasonal/perennial)
- Symptomatic relief of nasal congestion associated with the common cold or sinusitis
- Relief of nasal congestion prior to diagnostic procedures (e.g., nasoendoscopy)
4. Dosage & Administration
Adult Dosage: 2-3 drops or 1-2 sprays (approx. 0.1 mL) into each nostril. May be repeated every 8 to 10 hours as needed. Do not exceed 3 applications in 24 hours.
Administration: 1. Blow nose gently to clear nostrils. 2. Tilt head slightly back. 3. Insert applicator tip just inside nostril. 4. For sprays: Squeeze bottle quickly and firmly while breathing in gently through the nose. For drops: Instill prescribed number of drops. 5. Avoid touching the dropper/tip to the nostril to prevent contamination. 6. Do not share the bottle. 7. Use for a maximum of 5-7 consecutive days.
5. Side Effects
Common side effects may include:
- Transient local burning
- Stinging
- Sneezing
- Dryness of the nasal mucosa
- Mild headache
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Monoamine Oxidase Inhibitors (MAOIs) e.g., Phenelzine, Tranylcypromine | Risk of severe, potentially fatal hypertensive crisis due to potentiation of sympathomimetic effects. | Contraindicated |
| Tricyclic Antidepressants (TCAs) e.g., Amitriptyline | May potentiate the pressor effects of xylometazoline. | Major |
| Other Sympathomimetic Agents (e.g., Pseudoephedrine, Phenylephrine) | Additive sympathomimetic effects, increasing risk of hypertension, tachycardia, and CNS stimulation. | Moderate |
| Beta-blockers (e.g., Propranolol) | Unopposed alpha-adrenergic stimulation may lead to severe hypertension and bradycardia. | Moderate |
| Methyldopa | May potentiate pressor response. | Moderate |
7. Patient Counselling
- DO use exactly as directed by your doctor.
- DO not use for more than 5 to 7 consecutive days.
- DO not exceed the recommended dose or frequency.
- DO not share your nasal spray/drops with anyone.
- DO clean the applicator tip with a clean tissue after use.
- DO NOT use if the solution is discolored or contains particles.
- DO NOT tilt your head back too far when using drops to avoid swallowing the medicine.
8. Toxicology & Storage
Overdose: **Topical Overuse:** Severe rebound nasal congestion, hypertension, headache, anxiety, insomnia, palpitations. **Accidental Ingestion (especially in children):** CNS depression (marked drowsiness, lethargy, coma, hypotonia), hypothermia, bradycardia, hypotension, respiratory depression, miosis.
Storage: Store at room temperature (15-25°C), protected from light. Keep the bottle tightly closed. Keep out of reach and sight of children. Do not freeze.